Ortolá J, Castiñeiras M J, Fuentes-Arderiu X
Servei de Bioquímica Clínica, Hospital Prínceps d'Espanya, Barcelona, Spain.
Clin Chem. 1992 Jan;38(1):56-9.
The biological variation of several relative lipid quantities, calculated as the ratios between the concentrations of various serum lipids and apolipoproteins, has been estimated over a one-year period. The medians of the within-subject biological coefficient of variation, separated by sex when significant differences exist, were 15.4% for [apolipoprotein A-I]/[apolipoprotein B], 6.8% for [high-density lipoprotein (HDL)-cholesterol]/[cholesterol], 10.5% and 17.6% (women and men, respectively) for [HDL2-cholesterol]/[HDL-cholesterol], 13.6% for [HDL2-cholesterol]/[HDL3-cholesterol], 10.6% for [low-density lipoprotein (LDL)-cholesterol]/[apolipoprotein B], 10.6% and 8.7% (women and men, respectively) for [LDL-cholesterol]/[cholesterol], and 6.3% for [LDL-cholesterol]/[HDL-cholesterol]. From these data, we have calculated the critical difference for significant change detection, the index of individuality, and the goal for the between-day imprecision. Concerning within-subject biological variation, the best ratios for the detection of risk of coronary heart disease and the monitoring of intervention are [LDL-cholesterol]/[HDL-cholesterol] and [HDL-cholesterol]/[cholesterol]. The index of individuality obtained in this study indicates that the use of population-based reference values is inadequate for interpreting the ratios studied.
在一年时间内,对几种相对脂质含量的生物学变异进行了估算,这些相对脂质含量是以各种血清脂质和载脂蛋白浓度之间的比率计算得出的。当存在显著差异时,按性别划分的受试者内生物学变异系数中位数如下:载脂蛋白A-I/载脂蛋白B为15.4%,高密度脂蛋白(HDL)胆固醇/胆固醇为6.8%,HDL2胆固醇/HDL胆固醇分别为10.5%(女性)和17.6%(男性),HDL2胆固醇/HDL3胆固醇为13.6%,低密度脂蛋白(LDL)胆固醇/载脂蛋白B为10.6%,LDL胆固醇/胆固醇分别为10.6%(女性)和8.7%(男性),LDL胆固醇/HDL胆固醇为6.3%。根据这些数据,我们计算了用于显著变化检测的临界差异、个体性指数以及日间不精密度目标。关于受试者内生物学变异,用于检测冠心病风险和监测干预的最佳比率是LDL胆固醇/HDL胆固醇和HDL胆固醇/胆固醇。本研究中获得的个体性指数表明,使用基于人群的参考值来解释所研究的比率是不够的。